| 2 | Glycosphingolipids and their impact on platelet activity in a murine model of fabry disease. (Kanack AJ, Prodoehl E, Ishihara-Aoki M, Aoki K, Dahms NM) Sci Rep 2024 Nov 27;14(1):29488 1 Citation |
| 1 | Neural-specific alterations in glycosphingolipid biosynthesis and cell signaling associated with two human ganglioside GM3 synthase deficiency variants. (Dookwah M, Wagner SK, Ishihara M, Yu SH, Ulrichs H, Kulik MJ, Zeltner N, Dalton S, Strauss KA, Aoki K, Steet R, Tiemeyer M) Hum Mol Genet 2023 Dec 01;32(24):3323-3341 9 Citations |
| 1 | Progress in the understanding and treatment of Fabry disease. (Miller JJ, Kanack AJ, Dahms NM) Biochim Biophys Acta Gen Subj 2020 Jan;1864(1):129437 94 Citations |
| 1 | Recessive GM3 synthase deficiency: Natural history, biochemistry, and therapeutic frontier. (Bowser LE, Young M, Wenger OK, Ammous Z, Brigatti KW, Carson VJ, Moser T, Deline J, Aoki K, Morlet T, Scott EM, Puffenberger EG, Robinson DL, Hendrickson C, Salvin J, Gottlieb S, Heaps AD, Tiemeyer M, Strauss KA) Mol Genet Metab 2019 Apr;126(4):475-488 46 Citations |
| 4 | α-Galactosidase A-deficient rats accumulate glycosphingolipids and develop cardiorenal phenotypes of Fabry disease. (Miller JJ, Aoki K, Mascari CA, Beltrame AK, Sokumbi O, North PE, Tiemeyer M, Kriegel AJ, Dahms NM) FASEB J 2019 Jan;33(1):418-429 25 Citations |
| 3 | Neuropathic pain in a Fabry disease rat model. (Miller JJ, Aoki K, Moehring F, Murphy CA, O'Hara CL, Tiemeyer M, Stucky CL, Dahms NM) JCI Insight 2018 Mar 22;3(6) 58 Citations |
| 1 | Specific storage of glycoconjugates with terminal α-galactosyl moieties in the exocrine pancreas of Fabry disease patients with blood group B. (Rybová J, Kuchar L, Hulková H, Asfaw B, Dobrovolný R, Sikora J, Havlícek V, Škultéty L, Ledvinová J) Glycobiology 2018 Jun 01;28(6):382-391 7 Citations |
| 1 | Qrator: a web-based curation tool for glycan structures. (Eavenson M, Kochut KJ, Miller JA, Ranzinger R, Tiemeyer M, Aoki K, York WS) Glycobiology 2015 Jan;25(1):66-73 8 Citations |
| 1 | Phosphocholine-containing glycosyl inositol-phosphoceramides from Trichoderma viride induce defense responses in cultured rice cells. (Uchiyama R, Aoki K, Sugimoto H, Taka N, Katayama T, Itonori S, Sugita M, Che FS, Kumagai H, Yamamoto K) Biosci Biotechnol Biochem 2009 Jan;73(1):74-8 11 Citations |
| 1 | Structural characterization of glycosylinositolphospholipids with a blood group type B sugar unit from the edible mushroom, Hypsizygus marmoreus. (Itonori S, Yamawaki S, Aoki K, Yamamoto K, Hada N, Takeda T, Dulaney JT, Sugita M) Glycobiology 2008 Jul;18(7):540-8 7 Citations |
| 1 | Enzymatic and functional correction along with long-term enzyme secretion from transduced bone marrow hematopoietic stem/progenitor and stromal cells derived from patients with Fabry disease. (Takenaka T, Hendrickson CS, Tworek DM, Tudor M, Schiffmann R, Brady RO, Medin JA) Exp Hematol 1999 Jul;27(7):1149-59 39 Citations |
| 1 | Cell surface ligands for rotavirus: mouse intestinal glycolipids and synthetic carbohydrate analogs. (Srnka CA, Tiemeyer M, Gilbert JH, Moreland M, Schweingruber H, de Lappe BW, James PG, Gant T, Willoughby RE, Yolken RH) Virology 1992 Oct;190(2):794-805 37 Citations |
| 1 | Rotaviruses specifically bind to the neutral glycosphingolipid asialo-GM1. (Willoughby RE, Yolken RH, Schnaar RL) J Virol 1990 Oct;64(10):4830-5 55 Citations |
